Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Unknown 4Terminated 3Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × tegafur-gimeracil-oteracil × Clear all
NCT05346874 2022-05-26

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Shanghai Zhongshan Hospital

Phase 2 Unknown
37 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03904225 2021-06-23

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Zhejiang Cancer Hospital

Phase 2 Unknown
220 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

National Taiwan University Hospital

Phase 2 Unknown
38 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Xijing Hospital

Phase 2 Unknown
200 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡